Etomidate

CAS 33125-97-2 10 FDA-DMF suppliersSmall Molecule

Overview

Etomidate is a short-acting intravenous anesthetic agent used for the induction of general anesthesia and sedation for short procedures. It is known for its stable hemodynamic profile and minimal effect on cardiovascular function.

API suppliers (12)

Suppliers of Etomidate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • PISGAH LABS INC1 active DMF
  • PISGAH LABS INC1 active DMF
  • PISGAH LABS INC1 active DMF
  • PISGAH LABS INC1 active DMF
  • BACHEM INC1 active DMF
  • CHEMWERTH INC1 active DMF
  • BACHEM INC1 active DMF
  • CHEMWERTH INC1 active DMF
  • BACHEM INC1 active DMF
  • CHEMWERTH INC1 active DMF
  • Janssen Pharmaceutica NVBelgium
  • RELIABLE BIOPHARMACEUTICAL CORP

Therapeutic areas

AnesthesiologyCritical Care

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.